Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371:932-944.
Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77:3-14.
Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47:1-57.
1. Gershon A. Mumps. In: Fauci AS, Braunwald E, Kasper DL, et al. Harrison's principles of internal medicine. 17th ed. New York, NY: McGraw Hill Professional; 2008.
2. Hviid A, Rubin S, Muhlemann K. Mumps. Lancet. 2008;371:932-944.
3. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999;77:3-14.
4. Johnstone JA, Ross CA, Dunn M. Meningitis and encephalitis associated with mumps infection: a 10 year survey. Arch Dis Child. 1972;47:647-651.
5. Levitt LP, Rich TA, Kinde SW, et al. Central nervous system mumps: a review of 64 cases. Neurology. 1970;20:829-834.
6. Nussinovitch M, Volovitz B, Varsano I. Complications of mumps requiring hospitalization in children. Eur J Pediatr. 1995;154:732-734.
7. Peltola H, Heinonen P, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med. 1994;331:1397-1402.
8. Health Protection Agency. Notifications by age group, 1989-2009. September 2010. http://www.hpa.org.uk (last accessed 28 July 2011).
9. Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47:1-57.
10. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358:1580-1589.
11. Marin M, Quinlisk P, Shimabukuro T, et al. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine. 2008;26:3601-3607.
12. Centres for Disease Control and Prevention. Notifiable diseases and mortality tables. MMWR Morb Mortal Wkly Rep. 2014;63:ND213-ND226.
13. Public Health England. Measles: confirmed cases. April 2016. https://www.gov.uk/ (last accessed 27 February 2017).
14. Muhlemann K. The molecular epidemiology of mumps virus. Infect Genet Evol. 2004;4:215-219.
15. Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12-17.
16. deBoer AW, deVaan GAM. Mild course of mumps in patients with acute lymphoblastic leukaemia. Eur J Pediatr. 1989;148:618-619.
17. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62:1-34.
18. Public Health England. Immunisation against infectious disease. September 2014. https://www.gov.uk/ (last accessed 27 February 2017).
19. Immunization Action Coalition. Healthcare personnel vaccination recommendations. Item #P2017. July 2012. http://www.cdc.gov/vaccines/spec-grps/hcw.htm (last accessed 27 February 2017).
20. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2010 global summary. http://www.who.int (last accessed 27 March 2017).
21. Centers for Disease Control and Prevention. Vaccine information statement: MMR vaccine. April 2012. http://www.cdc.gov/ (last accessed 27 February 2017).
22. Hambidge SJ, Newcomer SR, Narwaney KJ, et al. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014;133:e1492-e1499.
23. Jokinen S, Osterlund P, Julkunen I, et al. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination. J Infect Dis. 2007;196:861-867.
24. Demicheli V, Rivetti A, Debalini MG, et al. Vaccines for measles, mumps and rubella in children. Evidence-Based Child Health. 2013;8:2076-2238.
25. Peltola H, Kulkarni PS, Kapre SV, et al. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis. 2007;45:459-466.
26. [No authors listed]. Retraction: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010;375:445.
27. Centers for Disease Control and Prevention. Mumps epidemic: Iowa, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:366-368.
28. Krause CH, Molyneaux PJ, Ho-Yen DO, et al. Comparison of mumps-IgM ELISAs in acute infection. J Clin Virol. 2007;38:153-156.
29. Centers for Disease Control and Prevention. Mumps vaccination. http://www.cdc.gov (last accessed 27 February 2017).
30. Boston Public Health Commission. Health alert: mumps outbreak. April 2006.
31. Perry KR, Brown DW, Parry JV, et al. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol. 1993;40:235-240.
32. Poggio GP, Rodriguez C, Cisterna D, et al. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J Clin Microbiol. 2000;38:274-278.
33. Overman JR. Viremia in humans mumps infections. AMA Arch Intern Med. 1958;102:354-256.
34. Whelan J, van Binnendijk R, Greenland K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill. 2010;15:pii=19554.
35. Manson AL. Mumps orchitis. Urology. 1990;36:355-358.
37. Public Health England. Guidance on infection control in schools and other childcare settings. September 2014. https://www.gov.uk/ (last accessed 27 February 2017).
38. Centers for Disease Control and Prevention (CDC). Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep. 2008;57:1103-1105.
39. Siegel M, Fuerst HT, Peress NS. Comparative fetal mortality in maternal virus diseases. A prospective study on rubella, measles, mumps, chicken pox and hepatitis. N Engl J Med. 1966;274:768-771.
40. Lane TM, Hines J. The management of mumps orchitis. BJU Int. 2006;97:1-2.
41. Vuori M, Lahikainen EA, Peltonen T. Perceptive deafness in connection with mumps: a study of 298 servicemen suffering from mumps. Acta Otolaryngol. 1962;55:231-236.
42. Everberg G. Deafness following mumps. Acta Otolaryngol. 1957;48:397-403.
43. Suskovic T, Vukicevic-Baudoin D, Vucicevic Z, et al. Severe pancreatitis as a first symptom of mumps complicated with pseudocyst and abscess of pancreas. Infection. 1997;25:39-40.
44. Ozkutlu S, Soylemezoglu O, Calikoglu AS, et al. Fatal mumps myocarditis. Jpn Heart J. 1989;30:109-114.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台